Raymond W. Barrett - Publications

1948 Stanford University, Palo Alto, CA 

46/53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 VanMeter SA, Kavanagh ST, Warren S, Barrett RW. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies. Cns Drugs. 26: 773-80. PMID 22849331 DOI: 10.2165/11634870-000000000-00000  0.01
2011 Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 7: 282-92. PMID 21677899 DOI: 10.5664/JCSM.1074  1
2010 Bogan RK, Bornemann MA, Kushida CA, Trân PV, Barrett RW. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clinic Proceedings. 85: 512-21. PMID 20511481 DOI: 10.4065/mcp.2009.0700  0.01
2009 Walters AS, Ondo WG, Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial. Clinical Neuropharmacology. 32: 311-20. PMID 19667976 DOI: 10.1097/WNF.0b013e3181b3ab16  0.01
2006 Yanofsky SD, Shen ES, Holden F, Whitehorn E, Aguilar B, Tate E, Holmes CP, Scheuerman R, MacLean D, Wu MM, Frail DE, López FJ, Winneker R, Arey BJ, Barrett RW. Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists. The Journal of Biological Chemistry. 281: 13226-33. PMID 16540466 DOI: 10.1074/jbc.M600601200  0.01
2004 Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, Barrett RW, Gallop MA. XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. The Journal of Pharmacology and Experimental Therapeutics. 311: 324-33. PMID 15146029 DOI: 10.1124/jpet.104.067959  1
2004 Cundy KC, Branch R, Chernov-Rogan T, Dias T, Estrada T, Hold K, Koller K, Liu X, Mann A, Panuwat M, Raillard SP, Upadhyay S, Wu QQ, Xiang JN, Yan H, ... Barrett RW, et al. XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters. The Journal of Pharmacology and Experimental Therapeutics. 311: 315-23. PMID 15146028 DOI: 10.1124/jpet.104.067934  1
2004 Maclean D, Holden F, Davis AM, Scheuerman RA, Yanofsky S, Holmes CP, Fitch WL, Tsutsui K, Barrett RW, Gallop MA. Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. Journal of Combinatorial Chemistry. 6: 196-206. PMID 15002967 DOI: 10.1021/Cc0300154  1
2003 Woiwode TF, Haggerty JE, Katz R, Gallop MA, Barrett RW, Dower WJ, Cwirla SE. Synthetic compound libraries displayed on the surface of encoded bacteriophage. Chemistry & Biology. 10: 847-58. PMID 14522055 DOI: 10.1016/j.chembiol.2003.08.005  0.01
2001 Uings IJ, Balasubramanian P, McLoughlin PG, Yin Q, Dash L, Beresford A, Kearney S, Barrett RW, McKinnon M, England BP. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity. Cytokine. 15: 10-9. PMID 11509004 DOI: 10.1006/cyto.2001.0886  0.01
2000 England BP, Balasubramanian P, Uings I, Bethell S, Chen MJ, Schatz PJ, Yin Q, Chen YF, Whitehorn EA, Tsavaler A, Martens CL, Barrett RW, McKinnon M. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. Proceedings of the National Academy of Sciences of the United States of America. 97: 6862-7. PMID 10823900 DOI: 10.1073/pnas.110053997  0.01
1999 Martens C, Bakker A, Rodriguez A, Mortensen RB, Barrett RW. A generic particle-based nonradioactive homogeneous multiplex method for high-throughput screening using microvolume fluorimetry. Analytical Biochemistry. 273: 20-31. PMID 10452795 DOI: 10.1006/abio.1999.4184  0.01
1998 Dower WJ, Cwirla SE, Balasubramanian P, Schatz PJ, Baccanari DP, Barrett RW. Peptide agonists of the thrombopoietin receptor. Stem Cells (Dayton, Ohio). 16: 21-9. PMID 11012174 DOI: 10.1002/stem.5530160705  0.01
1997 Wrighton NC, Balasubramanian P, Barbone FP, Kashyap AK, Farrell FX, Jolliffe LK, Barrett RW, Dower WJ. Increased potency of an erythropoietin peptide mimetic through covalent dimerization Nature Biotechnology. 15: 1261-1265. PMID 9359108 DOI: 10.1038/Nbt1197-1261  1
1997 Sloan DD, Barrett RW, Tate EH, England BP. Expression of an epitope tagged human C5a receptor and antibody-mediated immobilization of detergent-solubilized receptor for drug discovery screening. Protein Expression and Purification. 11: 119-24. PMID 9325147 DOI: 10.1006/prep.1997.0777  0.01
1997 Koller KJ, Whitehorn EA, Tate E, Ries T, Aguilar B, Chernov-Rogan T, Davis AM, Dobbs A, Yen M, Barrett RW. A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors. Analytical Biochemistry. 250: 51-60. PMID 9234898 DOI: 10.1006/abio.1997.2190  0.01
1997 Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science (New York, N.Y.). 276: 1696-9. PMID 9180079 DOI: 10.1126/science.276.5319.1696  0.01
1996 Akeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackermann BL, Chan KY, Robinson JL, Yanofsky SD, Jacobs JW, Barrett RW, Bowlin TL. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. The Journal of Biological Chemistry. 271: 30517-23. PMID 8940020 DOI: 10.1074/jbc.271.48.30517  0.01
1996 Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. Small peptides as potent mimetics of the protein hormone erythropoietin Science. 273: 458-463. PMID 8662529 DOI: 10.1126/Science.273.5274.458  1
1996 Sarubbi E, Yanofsky SD, Barrett RW, Denaro M. A cell-free, nonisotopic, high-throughput assay for inhibitors of type-I interleukin-1 receptor. Analytical Biochemistry. 237: 70-5. PMID 8660539 DOI: 10.1006/abio.1996.0202  0.01
1995 Whitehorn EA, Tate E, Yanofsky SD, Kochersperger L, Davis A, Mortensen RB, Yonkovich S, Bell K, Dower WJ, Barrett RW. A generic method for expression and use of "tagged" soluble versions of cell surface receptors. Bio/Technology (Nature Publishing Company). 13: 1215-9. PMID 9636295 DOI: 10.1038/nbt1195-1215  0.01
1995 Balasubramanian S, Chernov-Rogan T, Davis AM, Whitehorn E, Tate E, Bell MP, Zurawski G, Barrett RW. Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. International Immunology. 7: 1839-49. PMID 8580082 DOI: 10.1093/intimm/7.11.1839  0.01
1995 Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW. Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. European Journal of Biochemistry. 227: 838-47. PMID 7867645 DOI: 10.1111/j.1432-1033.1995.tb20209.x  0.01
1995 Schreuder H, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW. Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex. Febs Letters. 373: 39-40. PMID 7589429 DOI: 10.1016/0014-5793(95)01009-4  0.01
1994 Gordon EM, Barrett RW, Dower WJ, Fodor SP, Gallop MA. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. Journal of Medicinal Chemistry. 37: 1385-401. PMID 8182695 DOI: 10.1021/jm00036a001  1
1994 Gallop MA, Barrett RW, Dower WJ, Fodor SP, Gordon EM. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. Journal of Medicinal Chemistry. 37: 1233-51. PMID 8176700 DOI: 10.1021/jm00035a001  1
1993 Needels MC, Jones DG, Tate EH, Heinkel GL, Kochersperger LM, Dower WJ, Barrett RW, Gallop MA. Generation and screening of an oligonucleotide-encoded synthetic peptide library. Proceedings of the National Academy of Sciences of the United States of America. 90: 10700-4. PMID 7504279 DOI: 10.1073/PNAS.90.22.10700  0.01
1992 Barrett RW, Cwirla SE, Ackerman MS, Olson AM, Peters EA, Dower WJ. Selective enrichment and characterization of high affinity ligands from collections of random peptides on filamentous phage. Analytical Biochemistry. 204: 357-64. PMID 1443536 DOI: 10.1016/0003-2697(92)90252-3  1
1991 England BP, Ackerman MS, Barrett RW. A chimeric D2 dopamine/ml muscarinic receptor with D2 binding specificity mobilizes intracellular calcium in response to dopamine Febs Letters. 279: 87-90. PMID 1995348 DOI: 10.1016/0014-5793(91)80257-4  1
1991 Steffey ME, Snyder GL, Barrett RW, Fink JS, Ackerman M, Adams P, Bhatt R, Gomez E, MacKenzie RG. Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells. European Journal of Pharmacology. 207: 311-7. PMID 1664335 DOI: 10.1016/0922-4106(91)90005-3  1
1990 Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: A vast library of peptides for identifying ligands Proceedings of the National Academy of Sciences of the United States of America. 87: 6378-6382. PMID 2201029 DOI: 10.1073/pnas.87.16.6378  1
1990 Klueppelberg UG, Molero X, Barrett RW, Miller LJ. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells. Molecular Pharmacology. 38: 159-63. PMID 2200953  0.01
1989 Barrett RW, Steffey ME, Wolfram CAW. Type-A cholecystokinin binding sites in cow brain: Characterization using (-)-[3H]L364718 membrane binding assays Molecular Pharmacology. 36: 285-290. PMID 2770704  1
1989 Lin CW, Holladay MW, Barrett RW, Wolfram CAW, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: Studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33) Molecular Pharmacology. 36: 881-886. PMID 2601685  1
1989 McKinney M, Barrett RW. Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115. European Journal of Pharmacology. 162: 397-405. PMID 2568262 DOI: 10.1016/0014-2999(89)90330-0  0.01
1989 Barrett RW, Steffey ME, Wolfram CAW. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: Evidence for association with G protein and activation of phosphoinositide hydrolysis Molecular Pharmacology. 35: 394-400. PMID 2539554  1
1987 Goldstein A, Barrett RW. Ligand dissociation constants from competition binding assays: Errors associated with ligand depletion Molecular Pharmacology. 31: 603-609. PMID 3600604  1
1987 Vaught JL, Barrett RW. Modulation of morphine analgesia by opioid peptides. Implications for antinociceptive processes. Pain and Headache. 9: 178-93. PMID 2825157  0.01
1986 Peroutka SJ, Ison PJ, Liu DU, Barrett RW. Artifactual high-affinity and saturable binding of [3H]5-hydroxytryptamine induced by radioligand oxidation. Journal of Neurochemistry. 47: 38-45. PMID 3711910 DOI: 10.1111/j.1471-4159.1986.tb02828.x  0.01
1986 Barrett RW, James IF, Goldstein A. Comparative immuno-removal: A novel method for estimating the concentration of an unknown immunoreactive compound Biochemical and Biophysical Research Communications. 137: 316-322. PMID 3521606 DOI: 10.1016/0006-291X(86)91212-X  1
1985 Goldstein A, Barrett RW, James IF, Lowney LI, Weitz CJ, Knipmeyer LL, Rapoport H. Morphine and other opiates from beef brain and adrenal. Proceedings of the National Academy of Sciences of the United States of America. 82: 5203-7. PMID 3860854 DOI: 10.1073/pnas.82.15.5203  1
1985 Barrett RW, Goldstein A. A monoclonal antibody specific for a dynorphin precursor Neuropeptides. 6: 113-120. PMID 2860615 DOI: 10.1016/0143-4179(85)90102-7  1
1983 Barrett RW, Vaught JL. Comparison of the filtration and centrifugation methods for assaying [3H](D-ala2, D-leu5)enkephalin binding to mouse brain membranes. Neurochemical Research. 8: 1547-56. PMID 6369164 DOI: 10.1007/BF00964156  0.01
1983 Barrett RW, Vaught JL. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes. Life Sciences. 33: 2439-48. PMID 6316063 DOI: 10.1016/0024-3205(83)90638-0  0.01
1983 Rothman RB, Barrett RW, Vaught JL. Multidimensional analysis of ligand binding data: application to opioid receptors. Neuropeptides. 3: 367-77. PMID 6312362 DOI: 10.1016/0143-4179(83)90025-2  0.01
1982 Barrett RW, Vaught JL. The effects of receptor selective opioid peptides on morphine-induced analgesia. European Journal of Pharmacology. 80: 427-30. PMID 6286328 DOI: 10.1016/0014-2999(82)90090-5  0.01
Low-probability matches
2010 Lee D, Ziman R, Perkins A, Poceta J, Walters A, Barrett R. Gabapentin enacarbil improves pain associated with Restless Legs Syndrome (RLS) The Journal of Pain. 11: S53. DOI: 10.1016/J.JPAIN.2010.01.223  0.01
2009 Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW. A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Sleep. 32: 159-68. PMID 19238802 DOI: 10.1093/SLEEP/32.2.159  0.01
2009 Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology. 72: 439-46. PMID 19188575 DOI: 10.1212/01.wnl.0000341770.91926.cc  0.01
2009 Canafax D, Kushida C, Becker P, Ellenbogen A, Barrett R. Gabapentin enacarbil relieves the pain associated with Restless Legs Syndrome The Journal of Pain. 10: S42. DOI: 10.1016/J.JPAIN.2009.01.179  0.01
2009 Canafax D, Ellenbogen A, Becker P, Kushida C, Barrett R. Gabapentin enacarbil improves mood, quality of life and functioning in subjects with moderate-to-severe primary Restless Legs Syndrome The Journal of Pain. 10: S41. DOI: 10.1016/J.JPAIN.2009.01.175  0.01
1997 Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 386: 194-200. PMID 9062194 DOI: 10.1038/386194a0  0.01
1996 Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW, Balasubramanian P, Chinn JP, Cwirla SE, Peters-Bhatt E, Whitehorn EA, Tate EH, Akeson A, Bowlin TL, Dower WJ, Barrett RW. High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proceedings of the National Academy of Sciences of the United States of America. 93: 7381-6. PMID 8693002 DOI: 10.1073/PNAS.93.14.7381  0.01
Hide low-probability matches.